Scope Fluidics Spolka Akcyjna (FRA:S84) E10: €2.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
59 GF Score
Price €27.30
GF Value €25.53
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna E10?

Scope Fluidics Spolka Akcyjna FRA:S84 +3.61% 59 E10 is €2.28 as of Mar. 2026. GuruFocus rates FRA:S84 with a GF Score™ of 59/100 and a GF Value™ of €25.53 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Scope Fluidics Spolka Akcyjna's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.987. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €2.28 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-06), Scope Fluidics Spolka Akcyjna's current stock price is €27.30. Scope Fluidics Spolka Akcyjna's E10 for the quarter that ended in Mar. 2026 was €2.28. Scope Fluidics Spolka Akcyjna's Shiller PE Ratio of today is 11.97.

During the past 10 years, the highest Shiller PE Ratio of Scope Fluidics Spolka Akcyjna was 12.36. The lowest was 10.25. And the median was 10.72.


Scope Fluidics Spolka Akcyjna  (FRA:S84) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Scope Fluidics Spolka Akcyjna's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=27.30/2.28
=11.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Shiller P/E Ratio of Scope Fluidics Spolka Akcyjna was 12.36. The lowest was 10.25. And the median was 10.72.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Scope Fluidics Spolka Akcyjna E10 Related Terms


Scope Fluidics Spolka Akcyjna E10 Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna E10 Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.28

FRA:S84 vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Shiller PE Ratio falls into.


FRA:S84
59GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scope Fluidics Spolka Akcyjna's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.987/163.0700*163.0700
=-0.987

Current CPI (Mar. 2026) = 163.0700.

Scope Fluidics Spolka Akcyjna Quarterly Data

per share eps CPI Adj_EPS
201606 -0.050 99.552 -0.082
201609 -0.113 99.064 -0.186
201612 -0.029 100.366 -0.047
201703 -0.096 101.018 -0.155
201706 -0.087 101.180 -0.140
201709 -0.106 101.343 -0.171
201712 -0.126 102.564 -0.200
201803 -0.103 102.564 -0.164
201806 -0.069 103.378 -0.109
201809 -0.114 103.378 -0.180
201812 -0.095 103.785 -0.149
201903 -0.132 104.274 -0.206
201906 -0.115 105.983 -0.177
201909 -0.153 105.983 -0.235
201912 -0.229 107.123 -0.349
202003 -0.157 109.076 -0.235
202006 -0.056 109.402 -0.083
202009 -0.151 109.320 -0.225
202012 -0.241 109.565 -0.359
202103 -0.892 112.658 -1.291
202106 0.058 113.960 0.083
202109 -0.302 115.588 -0.426
202112 -0.302 119.088 -0.414
202203 -0.304 125.031 -0.396
202206 -0.337 131.705 -0.417
202209 29.020 135.531 34.917
202212 -1.036 139.113 -1.214
202303 -0.258 145.950 -0.288
202306 -0.214 147.009 -0.237
202309 -0.451 146.113 -0.503
202312 -0.678 147.741 -0.748
202403 -0.583 149.044 -0.638
202406 -0.562 150.997 -0.607
202409 -0.558 153.439 -0.593
202412 7.278 154.660 7.674
202503 -0.936 157.021 -0.972
202506 -0.729 157.509 -0.755
202509 -0.969 158.000 -1.000
202512 -1.257 158.320 -1.295
202603 -0.987 163.070 -0.987

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €2.28 mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a E10 of €2.28 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's E10 too high?
Scope Fluidics Spolka Akcyjna's current E10 is €2.28. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's E10 compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's E10 of €2.28 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current E10 is €2.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (FRA:S84) is currently considered Fairly Valued. The stock's GF Value™ is €25.53, compared to a current price of €27.30 — trading 6.9% above its estimated fair value. The current E10 is €2.28. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current E10 is €2.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be overvalued. The current stock price of €27.30 is trading 6.9% above its estimated GF Value™ of €25.53. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for FRA:S84:

  • E10: €2.28
  • GF Value™: €25.53 vs. price of €27.30 (6.9% above fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
59GF Score

Get the complete analysis for FRA:S84

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.30
Price
€25.53
GF Value